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Aims To investigate the relationships between coronary flow reserve (CFR), left ventricular (LV) systolic function, and
myocardial viability in patients with acute myocardial infarction (AMI).
Methods
and results
In 149 patients with a first AMI, we estimated CFR non-invasively and assessed LV systolic function with low-dose
dobutamine Doppler echocardiography (LDDE), which also identified viability. Resting echocardiographic variables
did not differ between patients with preserved (54.4%) and low CFR (45.6%). During LDDE, longitudinal LV function
was decreased [9.5 cm/s (8;11.3) vs. 10.6 cm/s (8.5;12.5), P ¼ 0.04] and end-systolic volume increased [49.5 mL
(38;66) vs. 42 (31;61), P ¼ 0.04] in patients with low compared with preserved CFR. Among 87 (58%) patients
with resting wall motion abnormalities, 28 met the criteria for viability. One of 53 (2%) met the criteria for viability
in patients with CFR ≤2 compared with 27 of 34 (79%) with CFR. 2, P, 0.0001.
Conclusion Resting echocardiographic parameters were similar in patient groups. During LDDE, patients with reduced CFR had
increased LV size and compromised longitudinal functionof LV andwere less likely to have evidenceofmyocardial viability.
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Introduction
Despite early reperfusion clinical outcome and recovery of myo-
cardial contractility after successful reperfusion are influenced by
the extent of microvascular damage and the persistence of viable
myocardium.1–3 As the optimal reperfusion therapy should
restore not only epicardial patency and flow but also myocardial
tissue perfusion, the evaluation of coronary flow reserve (CFR)
in patients with acute myocardial infarction (AMI) may be impor-
tant. Diminished CFR provides information about the ability of
compensating mechanisms in the vasomotor function of the myo-
cardium. A non-invasive estimate of CFR may be obtained using
transthoracic echocardiography that correlate well with CFR
measured by other methods.4,5
Although CFR and stress testing have been used to evaluate left
ventricular (LV) systolic recovery after AMI,6,7 little is known of the
relation between microvascular dysfunction and LV contractile
reserve and presence of viability in consecutive patients presenting
with ST-elevation (STEMI) or non-ST-elevation AMI (NSTEMI).
Therefore, our objective was to determine the association
between CFR and LV function in consecutive patients with AMI.
Methods
Study population
Between January 2006 and August 2008, 190 patients with first AMI
admitted to the coronary care unit at Funen Hospital, Svendborg,
Denmark were consecutively screened. Inclusion criteria were: (i)
documented AMI (dynamic rise in Tn-T .0.1 mg/L, as well as either
typical symptoms, characteristic electrocardiographic changes, or
both); (ii) left anterior descending artery (LAD) without any stenosis
exceeding 50% by coronary angiography; (iii) an echocardiographic
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window allowing assessment of CFR; (iv) no prior history of documen-
ted AMI, coronary bypass surgery, valvular heart disease, and poorly
controlled obstructive airways disease; and (vi) no ventricular arrhyth-
mias. Four patients were excluded because of inability to detect cor-
onary flow. Three were excluded because of significant stenosis in
LAD. Thirty-four patients did not have low-dose dobutamine echocar-
diography (LDDE), 27 because of ventricular ectopy or non-sustained
ventricular tachycardia, four patients refused testing and three patients
had inadequate echocardiographic image quality. Thus, the final study
population consisted of 149 patients.
Patients presenting with STEMI within 12 h of onset of symptoms
were transferred to a tertiary centre where emergency percutaneous
coronary intervention (PCI) was performed. Fibrinolysis was not used
in any patients. In patients presenting with NSTEMI, initial antithrom-
botic treatment was instituted and subsequent angiography performed
within 4 days (IQR 3;6).
The study protocol was approved by the Regional Ethics Committee
of Southern Denmark, and the Danish Data Protection Agency, and
written informed content was obtained from all participating patients.
Two-dimensional and dobutamine Doppler
echocardiography
Transthoracic echocardiography was performed median 5 days3,8 after
enrolment using a commercially available ultrasound system (Vivid 7,
GE Medical Systems, Inc., Horten, Norway). All images were analysed
offline by a single investigator, blinded to all clinical data. After assess-
ment of CFR, patients rested for at least 5 min to ensure that the effect
of adenosine had ceased and subsequently, LDDE was performed.
Assessment of coronary flow reserve
The CFR studies were performed in an angiographically non-
obstructed LAD (,50%). If a significant stenosis was revealed during
angiography, CFR was assessed after the vessel was revascularized.
CFR was assessed in the distal part of LAD. After baseline record-
ings of flow velocity, adenosine was administered by intravenous infu-
sion (140 mg/kg/min) for 90 s. During infusion, hyperaemic flow
profiles were recorded.8,9 The CFR was estimated to be the ratio of
hyperaemic to baseline peak diastolic coronary flow velocities
(Figure 1). A. CFR . 2 was considered normal and the population
dichotomized according to this.8 All of the subjects abstained from
caffeine-containing drinks for at least 12 h before testing.
The intra- and interobserver variability of CFR was assessed in 20
consecutive patients, who underwent dual assessment of coronary
flow by two experienced co-investigators. These recordings were ana-
lysed by two experienced observers.
Resting echocardiography
From two-dimensional images, regional myocardial function was
assessed using regional wall motion according to current guidelines.10
A wall motion score index (WMSI) was calculated by dividing the sum
of scores by the number of visualized segments. LV end-diastolic and
end-systolic volumes were measured using biplane planimetry in long-
axis views and LV ejection fraction (LVEF) calculated. Longitudinal LV
systolic function was assessed using peak systolic velocity measured
with pulsed wave tissue Doppler echocardiography. From apical
four- and two-chamber views, the velocities were recorded at four
sites corresponding to the septal, anterior, lateral, and posterior
mitral annulus and the mean value from these four sites was calculated.
Stroke volume (SV) and cardiac output (CO) were calculated using the
LV outflow tract (LVOT) area and time velocity integral from pulse-
wave Doppler recording of LVOT flow. SV was calculated as p ×
(LVOTdiameter/2)
2 × stroke length. CO was calculated as SV × heart
rate.
Low-dose dobutamine echocardiography
After resting images were obtained, LDDE was performed. Dobuta-
mine was infused at dosages of 5 and 10 mg/kg/min for 3 min of each
dose. All images were repeated after 3 min infusion of 10 mg/kg/min
dobutamine. Pharmacological therapy including beta-blocking agents
was not withheld for ethical reasons. Contractile reserve was calcu-
lated as LVEFLDDE 2 LVEFrest. Viability was assessed in patients with
resting wall motion abnormalities and defined as improved contraction
in more than two contiguous segments and a decrease of .0.22 in
WMSI. Improved segmental wall motion during LDDE was defined
as previously suggested.11
Statistical analysis
Analyses were conducted with STATA/MP 10.0 (StataCorp LP, TX,
USA). Data are presented as median (inter-quartile range) and com-
pared using Kruskal–Wallis equality-of-populations rank tests for con-
tinuous variables, whereas categorical variables are presented as
counts (percentage) and compared using x2 tests. As significance
tests for baseline characteristics are presented for descriptive pur-
poses only, no adjustment for multiple testing was done.
Univariable logistic regression analysis was used to evaluate relation
between various clinical, echocardiographic and angiographic variables,
and viability. Variables identified in univariable analysis as predictors of
viability were subsequently tested in a multivariable model. A P, 0.05
was considered statistically significant.
Results
Clinical characteristics of the study
population
Clinical characteristics are shown in Table 1. Patients with CFR ≤ 2
were older and more frequently males and presented with higher
heart rate at admission. In contrast, no difference was found in
Killip classification (P ¼ 0.83), in the type of infarction (STEMI vs.
NSTEMI), culprit vessel or enzymatic size of AMI (P ¼ 0.64, P ¼
0.87, and P ¼ 0.39, respectively).
Resting left ventricular function
Therewas no significant difference in restingWMSI, LV end-diastolic,
LV end-systolic volumes, or systolic mitral annular velocity (s′)
in patients with normal compared with abnormal CFR. We
found a slight, but significant, difference in Doppler estimated CO
(Table 2).
Left ventricular function and
haemodynamic response during
dobutamine stimulation
During LDDE, LV end-systolic volume, and WMSI were reduced
and s′ increased in patients with a normal CFR (CFR. 2)
(Table 2). In contrast, the change of LVEF, LV end-diastolic
volume, CO and SV during LDDE were similar for both groups.
In patients with impaired CFR, LVEF improved 8% (0;14%) and
SV increased 13.9 mL (7.6;24.5), P ¼ 0.0002 and P, 0.00001 com-
pared with rest, respectively, during LDDE. In patients with
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preserved CFR, the change in LVEF was 8% (0;15%) and 13.8 mL
(3.8;21.9) in SV, P ¼ 0.0001 and P ¼ 0.00001, respectively.
Myocardial viability
Among 87 patients (58%) with resting wall motion abnormalities,
28 (32%) met the criteria for viability. One of 53 (2%) with
CFR ≤ 2 met the criteria for viability compared with 27 of 34
patients (79%) with CFR. 2, P, 0.0001. Additionally, after
adjustment for age, gender, resting heart rate, resting LVEF,
resting blood pressure, STEMI vs. NSTEMI, culprit vessel, and enzy-
matic size of AMI, the absence of viability in the 87 patients with
resting wall motion abnormalities was highly significantly associated
with decreased microcirculation, P, 0.0001.
In patients with resting wall motion abnormalities, baseline LV
systolic function assessed with LVEF was 44% (36;51) in patients
with CFR ≤ 2 and 44% (35;51) in patients with normal CFR,
P ¼ 0.95. Furthermore, SV and s′ were also similar in both
groups. SV and s′ in CFR ≤ 2 were 64.1 mL (52.9;77.3) and
6.7 cm/s (6;8.1) and in the group with normal CFR SV was
62.3 mL (52.6;71.5) and s′ was 6.7 cm/s (6.0;8.1), P ¼ 0.57 and
P ¼ 0.95, respectively.
Among patients with resting wall motion abnormalities, change
in LVEF was 8% (0;16) in patients with CFR ≤ 2 and 12% (5;17)
in patients with CFR. 2, P ¼ 0.1, and change in SV was 14.2 ml
[4;21.7] in patients with CRF ≤2 and 11.5 l/min [6.2;25.4] in
patients with CFR .2 P ¼ 0.84. Furthermore, changes in s′ were
2.0 cm/s [1.3;3.1] in patients with CFR ≤2 and 2.5 cm/s
[1.6;3.55] in patients with CFR .2 in this subgroup, P ¼ 0.1.
The intra- and interobserver variability of
coronary flow reserve
The interobserver variability were baseline coronary flow: mean
difference: 0.003; 95% limits of agreement (LOA): 20.03 to 0.04;
CV: 5.3% and CFR: mean difference: 0.004; 95% LOA: 20.04 to
Figure 1 Coronary flow reserve response in two patients with STEMI and culprit in LAD. Normal CFR ¼ 2.2 (top) and diminished CFR ¼ 1.1
(bottom).
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Table 2 Echocardiographic findings at baseline and low-dose dobutamine Doppler echocardiography
CFR ≤ 2 CFR > 2 P-value
Baseline
LVEDV (mL) 118 (97;141) 108 (93;124) 0.13
LVESV (mL) 57.5 (46;78) 51 (40;66) 0.11
WMSI 1.19 (1;1.63) 1.13 (1;1.44) 0.2
LVEF (%) 52 (42;57) 54 (44;60) 0.2
s′ (cm/s) 7.0 (6.3;8.6) 7.2 (6.3;8.5) 0.7
Stroke volume (mL) 67 (57;77) 64 (54;74) 0.27
Cardiac output (L/min) 4.4 (3.7;5.2) 3.8 (3.2;4.8) 0.02
Dobutamine stimulation
LVEDV (mL) 121.5 (100;153) 114 (99;134) 0.1
LVESV (mL) 49.5 (38;66) 42 (31;61) 0.04
WMSI 1.09 (1.00;1.56) 1.00 (1.00;1.13) 0.01
LVEF (%) 61 (55;68) 60 (49;66) 0.9
s′ (cm/s) 9.5 (8.0;11.3) 10.6 (8.5;12.5) 0.04
Stroke volume (mL) 83 (67;97) 80 (62;97) 0.72
Cardiac output (L/min) 5.8 (4.7;6.6) 5.2 (4.2;6.9) 0.6
Reserves
LVEDV (mL) 2.5 (211;21) 3 (27;19) 0.98
LVESV (mL) 25 (219;4) 28 (217;1) 0.76
WMSI 0 (0;0.0625) 0.005 (0;0.3) ,0.00001
LVEF (%) 8 (0;14) 8 (0;15) 0.44
s′ (cm/s) 2.25 (1.3;3.25) 2.9 (1.8;4.3) 0.002
Stroke volume (mL) 13.8 (3.8;21.9) 13.9 (7.6;24.5) 0.5
Cardiac output (L/min) 1.1 (0.4;2.1) 1.6 (0.6;2.2) 0.16
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; WMSI, wall motion score index; LVEF, left ventricular ejection fraction; s′ , systolic mitral
annular velocity.
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Table 1 Clinical characteristics
CFR ≤ 2 CFR > 2 P-value
Patients, n 86 63
Age (years) 64 (58;74) 58 (51;68) 0.009
Gender (female/male) 24/62 16/47 0.12
Height (cm) 174.5 (167;180) 174 (168;179) 0.84
Weight (kg) 80.4 (69.7;90) 80 (71;90.6) 0.82
BMI (kg/m2) 26.6 (23.1;29.6) 27.1 (23.8;30.1) 0.43
Systolic BP (mmHg) 140 (122;160) 138 (121;157) 0.8
Diastolic BP (mmHg) 80 (70;95) 80 (75;90) 0.6
Heart rate (b.p.m.) 65 (58;73) 60 (54;68) 0.044
Total cholesterol (mmol/L) 4.2 (3.8;5) 4.7 (3.9;5.4) 0.02
LDL (mmol/L) 2.4 (2.1;3) 2.8 (2.1;3.3) 0.12
HDL (mmol/L) 1.1 (0.86;1.37) 1.2 (0.92;1.37) 0.4
Triglyceride (mmol/L) 1.33 (0.89;1.67) 1.22 (0.9;1.6) 0.9
Troponine-T (mg/L) 1 (0.39;4.47) 1.05 (0.29;2.53) 0.3
Current smoker, n 46 37 0.4
fBG (mmol/L) 5.6 (5.3;6.3) 5.6 (5.2;6.1) 0.25
STEMI/NSTEMI, n 37/49 31/32 0.22
CFR, coronary flow reserve; BMI, body mass index; BP, blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; fBG, fasting blood glucose; STEMI,
ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction.
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0.04; CV: 11.1%. The intraobserver variability were as follows:
baseline coronary flow: mean difference: 0.001; 95% LOA:
20.028 to 0.03; CV: 3.6% and CFR: mean difference: 20.002;
95% LOA: 20.03 to 0.02; CV: 10.2%.
Angiographic and angioplasty data
Angiographic data in patient groups are seen in Table 3. In 49
patients, PCI was performed in the LAD; 45 patients achieved
TIMI 3 flow in the LAD and 4 TIMI 0–2 flow. Drug-eluting
stents were implanted in 109 patients and 45 patients received
eptifibatid/abciximab infusion during and after the PCI procedure.
Discussion
The present study demonstrates that, early after an AMI, the
microcirculation, in patients with successful revascularization,
remains compromised in a large proportion of patients. Although
resting LV function appears unaffected, patients with intact micro-
circulation are more likely to have viable myocardium suggestive of
a better potential for functional recovery after AMI.
In the present study, CFR was assessed in the early post-AMI
phase, which is opposed to most other studies where CFR was
assessed in stable patients with known or suspected coronary
artery disease. We found that CFR frequently was depressed.
Apparently, this had little effect on resting LV size, regional,
global, and longitudinal function. As many patients presented
with minor LV damage and preserved global LV function, the
study may lack power to detect subtle differences in resting func-
tion. This observation is in agreement with studies of stable
patients with minor or normal LV function.12–14 Importantly,
these studies suggested a prognostic importance of CFR despite
no apparent effect on LV function.
LDDE is well suited for the assessment of viability and assess-
ment of contractile reserve.15,16 As outlined in the expert consen-
sus statement from the Association of Echocardiography,17 the
combination of LDDE and CFR assessment could be beneficial.
Using this technique, we were able for the first time to detect
several consequences of reduced CFR early after AMI. Although
LV end-systolic volume at rest were similar in patients with a
reduced CFR, we observed a significant difference during LDDE
where end-systolic volume increased in patients with decreased
CFR this was associated with a lack of improvement in WMSI.
As opposed to this WMSI improved in patients with intact
microcirculation.
Echocardiographic determination of myocardial motion by
tissue Doppler is a reliable method for assessing the performance
of longitudinal oriented LV fibres. These fibres are mainly distribu-
ted within the subendocardium,18,19 rendering them vulnerable for
ischaemic microvascular damage. This may explain our observation
that patients with decreased CFR did not improve LV longitudinal
function during LDDE. It could be speculated that this could
increase the risk for LV dysfunction and adverse LV
remodelling.20,21
In patients with resting wall motion abnormalities, we found CFR
to be closely associated with myocardial viability. The data indicate
that patients with microvascular dysfunction had a very low likeli-
hood of having viable myocardium A previous study have
suggested that the presence of myocardial viability is related to a
more favourable outcome compared with those without viability.22
This could provide an important link between CFR and risk strati-
fication in patients suffering from AMI. Probably, the methods
should be viewed as complementary rather than alternative diag-
nostic tools. An important finding in the present study is that
the current management of AMI does not appear to restore micro-
vascular integrity in a large proportion of patients.
The subgroup of patients with decreased CFR included patients
with resting wall motion abnormalities as well as patients with pre-
served wall motion. We were not able to identify any variable that
could explain the difference in wall motion in these patients. The
difference in CFR may be explained by subendocardial decreased
perfusion of limited extent to decrease regional CFR but not
severe enough and/or transmurally extended to give rise to dys-
functional LV function, at least not enough to be characterized
with echocardiography.23–25
Study limitations
Our findings may reflect increased microvascular dysfunction with
increased macrovascular disease. As mentioned, our patients pre-
sented with minor LV damage and preserved global LV function
which may be of great importance interpreting the data. Especially
in relation to the viability testing in patients a near normal LV func-
tion. Both groups (normal and abnormal CFR) have a small dys-
function which may affect the results. Furthermore, beta-blocking
agents were not withheld for ethical reasons and we cannot
exclude that dobutamine sensitivity might have been affected. Fur-
thermore, the relatively low median CFR observed may be a result
of generalized myocardial microvascular impairment in post-AMI
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .






No significant vessel disease, n (%) 6 (7) 8 (13) 0.18
One-vessel disease, n (%) 49 (57) 40 (63) 0.42
Two-vessel disease, n (%) 23 (27) 11 (18) 0.18
Three-vessel disease, n (%) 8 (9) 4 (6) 0.51
Culprit lesion
Left anterior descending, n (%) 39 (45) 27 (42) 0.87
Right coronary artery, n (%) 31 (36) 18 (29) 0.34
Left circumflex, n (%) 16 (19) 18 (29) 0.1
Coronary angiography before intervention
TIMI flow grade
0, n (%) 35 (41) 26 (41) 0.62
1/2, n (%) 18 (21) 9 (14) 0.43
3, n (%) 33 (38) 28 (44) 0.46
Coronary angiography after intervention
TIMI flow grade
0, n (%) 3 (3) 0 (0) 0.13
1/2, n (%) 9 (11) 6 (10) 0.53
3, n (%) 74 (86) 57 (90) 0.41
CFR, coronary flow reserve; TIMI, thrombolysis in myocardial infarction.
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patients. We only performed CFR assessment in the LAD which
may lead to cautiousness interpreting the data concluding the
general microvascular function, even though this did not seem to
have any influence (Table 3). The reason for this approach was
to illustrate the usefulness of CFR in conjunction with LDDE in a
consecutive AMI population. It has been demonstrated with
several techniques that microcirculatory dysfunction affects the
left ventricle globally26 therefore CFR assessment in the LAD is
an acceptable option for evaluating global coronary microcircula-
tion conditions.
Although assessment of CFR has been validated against invasive
measures of CFR, the accuracy is influenced by image quality and
angle dependence of Doppler velocities which may limit the cor-
rectness in the individual patient.
Clinical implications
In conclusion, the presence of viability by LDDE is associated with
normal microvascular function and reserve. Our study strongly
suggests that CFR measured non-invasively after AMI is an indi-
cator of microvascular integrity and of myocardial viability.
Decreased microcirculation was associated with an abnormal
response of the ischaemic heart to LDDE. This study illustrates
the relationship between CFR and LV systolic function. Further
investigation of patients with decreased microcirculation is
indicated.
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